In vitro targeted magnetic delivery and tracking of superparamagnetic iron oxide particles labeled stem cells for articular cartilage defect repair

Abstract

To assess a novel cell manipulation technique of tissue engineering with respect to its ability to augment superparamagnetic iron oxide particles (SPIO) labeled mesenchymal stem cells (MSCs) density at a localized cartilage defect site in an in vitro phantom by applying magnetic force. Meanwhile, non-invasive imaging techniques were use to track SPIO-labeled MSCs by magnetic resonance imaging (MRI). Human bone marrow MSCs were cultured and labeled with SPIO. Fresh degenerated human osteochondral fragments were obtained during total knee arthroplasty and a cartilage defect was created at the center. Then, the osteochondral fragments were attached to the sidewalls of culture flasks filled with phosphate-buffered saline (PBS) to mimic the human joint cavity. The SPIO-labeled MSCs were injected into the culture flasks in the presence of a 0.57 Tesla (T) magnetic force. Before and 90 min after cell targeting, the specimens underwent T2-weighted turbo spin-echo (SET2WI) sequence of 3.0 T MRI. MRI results were compared with histological findings. Macroscopic observation showed that SPIO-labeled MSCs were steered to the target region of cartilage defect. MRI revealed significant changes in signal intensity (P<0.01). HE staining exibited that a great number of MSCs formed a three-dimensional (3D) cell “sheet” structure at the chondral defect site. It was concluded that 0.57 T magnetic force permits spatial delivery of magnetically labeled MSCs to the target region in vitro. High-field MRI can serve as an very sensitive non-invasive technique for the visualization of SPIO-labeled MSCs.

Keywords

superparamagnetic iron oxide particles / human bone-derived mesenchymal stem cells (hbMSCs) / cartilage defect / magnetic resonance imaging (MRI) / magnetic targeting cell delivery system / cell therapy

References

[1] BrowneJ.E., BranchT.P.. Surgical alternatives for treatment of articular cartilage lesions. J Am Acad Orthop Surg, 2000, 8(3): 180-189

[2] O’DriscollS.W.. The healing and regeneration of articular cartilage. J Bone Joint Surg Am, 1998, 80(12): 1795-1812

[3] KogaH., EngebretsenL., BrinchmannJ.E., et al.. Mesenchymal stem cell-based therapy for cartilage repair: a review. Knee Surg Sports Traumatol Arthrosc, 2009, 17(11): 1289-1297

[4] PittengerM.F., MackayA.M., BeckS.C., et al.. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284(5411): 143-147

[5] LeeK.B.L., HuiJ.H.P., SongI.C., et al.. Injectable mesenchymal stem cell therapy for large cartilage defects — A porcine model. Stem Cells, 2007, 25(11): 2964-2971

[6] AgungM., OchiM., YanadaS., et al.. Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg Sports Traumatol Arthrosc, 2006, 14(12): 1307-1314

[7] BrazeltonT.R., BlauH.M.. Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells, 2005, 23(9): 1251-1265

[8] KyrtatosP.G., LehtolainenP., Junemann-RamirezM., et al.. Magnetic tagging increases delivery of circulating progenitors in vascular injury. JACC Cardiovasc Interv, 2009, 2(8): 794-802

[9] PislaruS.V., HarbuzariuA., GulatiR., et al.. Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol, 2006, 48(9): 1839-1845

[10] JingX.H., YangL., DuanX.J., et al.. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. J Bone Spine, 2008, 75(4): 432-438

[11] JohnstoneB., YooJ.. Bone marrow-derived mesenchymal progenitor cells. Methods Mol Biol, 2000, 137: 313-315

[12] WangZ.Y., LiuG., SunJ., et al.. Self-assembly of magnetite nanocrystals with amphiphilic polyethylenimine: structures and applications in magnetic resonance imaging. J Nanosci Nanotechnol, 2009, 9(1): 378-385

[13] KobayashiT., OchiM., YanadaS., et al.. Augmentation of degenerated human cartilage in vitro using magnetically labeled mesenchymal stem cells and an external magnetic device. Arthroscopy, 2009, 25(12): 1435-1441

[14] KobayashiT., OchiM., YanadaS., et al.. A novel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair. Arthroscopy, 2008, 24(1): 69-76

[15] ItoA., HibinoE., KobayashiC., et al.. Construction and delivery of tissue-engineered human retinal pigment epithelial cell sheets, using magnetite nanoparticles and magnetic force. Tissue Eng, 2005, 11(3–4): 489-496

[16] MizunoK., MunetaT., MoritoT., et al.. Exogenous synovial stem cells adhere to defect of meniscus and differentiate into cartilage cells. J Med Dent Sci, 2008, 55(1): 101-111

[17] KogaH., ShimayaM., MunetaT., et al.. Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Res Ther, 2008, 10(4): R84

[18] YokoyamaA., SekiyaI., MiyazakiK., et al.. In vitro cartilage formation of composites of synovium-derived mesenchymal stem cells with collagen gel. Cell Tissue Res, 2005, 322(2): 289-298

[19] KogaH., MunetaT., NagaseT., et al.. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res, 2008, 333(2): 207-215

[20] LangerR., VacantiJ.P.. Tissue engineering. Science, 1993, 260(5110): 920-926

[21] O’GradyJ.E., BordonD.M.. Global regulatory registration requirements for collagen-based combination products: points to consider. Adv Drug Deliv Rev, 2003, 55(12): 1699-1721

[22] MarijnissenA.C.A., LafeberF.. Re: E. B. Hunziker. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis and Cartilage, 2002, 10(6): 432-63

[23] AndoW., TateishiK., HartD.A., et al.. Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials, 2007, 28(36): 5462-5470

[24] OshimaY., WatanabeN., MatsudaK., et al.. Behavior of transplanted bone marrow-derived GFP mesenchymal cells in osteochondral defect as a simulation of autologous transplantation. J Histochem Cytochem, 2005, 53(2): 207-216

[25] QuintavallaJ., Uziel-FusiS., YinJ., et al.. Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects. Biomaterials, 2002, 23(1): 109-119

[26] RieglerJ., WellsJ.A., KyrtatosP.G., et al.. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials, 2010, 31(20): 5366-5371